PM101: intravenous amiodarone formulation changes can improve medication safety. - Wikidata - awgldk - TriplyDB

PM101: intravenous amiodarone formulation changes can improve medication safety.

PM101: intravenous amiodarone formulation changes can improve medication safety.

http://www.wikidata.org/entity/Q37674638

about

Resuscitation Outcomes Consortium-Amiodarone, Lidocaine or Placebo Study (ROC-ALPS): Rationale and methodology behind an out-of-hospital cardiac arrest antiarrhythmic drug trial.Cardiovascular collapse during amiodarone infusion in a hemodynamically compromised child with refractory supraventricular tachycardia.Optimizing atrial fibrillation management: from ICU and beyond.Hepatic Dysfunction in Patients Receiving Intravenous Amiodarone Dantrolene versus amiodarone for cardiopulmonary resuscitation: a randomized, double-blinded experimental study.Amiodarone (Nexterone) injection for the treatment and prophylaxis of frequently recurring ventricular fibrillation.Safety of Polysorbate 80 in the Oncology Setting.Comedication with interacting drugs predisposes amiodarone users in cardiac and surgical intensive care units to acute liver injury: A retrospective analysis

P2860

Q33583415-6D603647-F06C-47EE-A330-A92D1FD4A66C Q35065891-54535155-A182-44DD-9D69-9195D2350982 Q36125219-08ED6DFD-F4BC-4A2E-A940-CE8F30DC2A71 Q36550859-C5268A5E-826D-4857-A871-C012FE432514 Q37591133-9E7FE4A5-4842-473D-9424-BFE26359CE98 Q37979244-126DB6D8-5A8B-4EC4-AC4C-3563DC91BF34 Q55405018-9D14E98B-515C-4AAA-904C-68A161114112 Q58739485-4D0BB203-E424-4714-B545-4FCF8EA4FF5B

P2860

PM101: intravenous amiodarone formulation changes can improve medication safety.

http://www.wikidata.org/entity/Q37674638

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

PM101: intravenous amiodarone formulation changes can improve medication safety.

@en

PM101: intravenous amiodarone formulation changes can improve medication safety.

@nl

type

label

PM101: intravenous amiodarone formulation changes can improve medication safety.

@en

PM101: intravenous amiodarone formulation changes can improve medication safety.

@nl

prefLabel

PM101: intravenous amiodarone formulation changes can improve medication safety.

@en

PM101: intravenous amiodarone formulation changes can improve medication safety.

@nl

P1433

Q37674638-95F6B8EC-D79B-4996-B12F-E84DA4AECA32

P1476

Q37674638-94FA0CB2-6CC8-4062-9CB3-A6B54D638C8D

P2093

Q37674638-1C97D303-AC66-4C7E-B1FF-44BB4BF7BBD5

Q37674638-C0F9288B-4432-4EE2-9525-1175DCDEA560

Q37674638-D2C55C5D-3D61-40D0-BD1C-05D86BD66C1A

P2860

Q37674638-0D39D45D-29EE-4A26-B9EC-8744DE5EF0CF

Q37674638-0EAC8E35-F3A9-4EB6-9262-28173E64E16B

Q37674638-150272BC-546E-4C94-9080-059C3D4808E3

Q37674638-15A56CE3-3764-4856-B903-5FD6EFC352B1

Q37674638-1AA13897-0FC3-488F-B4E5-CBAAC663FABF

Q37674638-1CD6D691-9745-48F7-8C74-F53E815BFAD1

Q37674638-269CE8AD-4E16-4348-9BAD-BFB52ED150B5

Q37674638-2BB368BF-1C86-495B-BD39-8B0DC232BF5A

Q37674638-327576EB-9343-479A-BC73-908D62DD78F8

Q37674638-3693119D-B31F-402F-99DE-DE2BA200337E

P304

Q37674638-3BE10C1C-7C5F-4399-91D0-49488B138195

P31

Q37674638-002B1072-51D1-4E07-B5D6-299146E0AB0E

P356

Q37674638-601BBEAD-3096-4402-8E27-367AF8C1A612

P407

Q37674638-65EF625D-4FC1-4247-97D0-4D668D424664

P433

Q37674638-45FF8708-D8EA-4022-8234-43C37E4FFDF3

P478

Q37674638-A19C73ED-4258-46BC-961E-D34F11EEFC08

P577

Q37674638-F4A99D9B-3D01-4FCD-B8FF-452039C0B38A

P698

Q37674638-2E2B648E-6E8A-4722-9C03-A50B54A01163

P356

14740331003586811

P1433

Expert Opinion on Drug Safety

P1476

PM101: intravenous amiodarone formulation changes can improve medication safety.

@en

P2093

Daniel J Cushing

http://www.w3.org/2001/XMLSchema#string

Paul F Souney

http://www.w3.org/2001/XMLSchema#string

Warren D Cooper

http://www.w3.org/2001/XMLSchema#string

P2860

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

The gasping syndrome and benzyl alcohol poisoning

Pharmacological effects of formulation vehicles : implications for cancer chemotherapy.

Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Grou

Conversion of recent-onset atrial fibrillation with intravenous amiodarone: a meta-analysis of randomized controlled trials.

Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation.

ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiolo

The quest for an aqueous amiodarone.

Tocol emulsions for drug solubilization and parenteral delivery.

P304

319-333

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14740331003586811

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20074019

http://www.w3.org/2001/XMLSchema#string